Back

Notification report


Full notification file


General information

Notification Number
B/DE/19/PEI3486

Member State to which the notification was sent
Germany

Date of acknowledgement from the Member State Competent Authority
09/07/2018

Title of the Project
A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector–Mediated Gene Transfer of Human Factor VIII in Hemophilia A Patients with Residual FVIII Levels ≤ 1 IU/dL Receiving Prophylactic FVIII Infusions

Proposed period of release:
01/11/2018 to 30/04/2019

Name of the Institute(s) or Company(ies)
BioMarin Pharmaceutical Inc., ;


3. Is the same GMO release planned elsewhere in the Community?
Yes:
Spain;

Has the same GMO been notified elsewhere by the same notifier?
Yes

If yes, notification number(s):
B/ES/18/11;

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
Genus: Dependovirus,
Species: Adeno-associated virus/ serotype 5 (AAV 5)


Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
Adeno-associated virusDependovirusAdeno-associated VirusSerotype 5--

European Commission administrative information

Consent given by the Member State Competent Authority:
Yes
09/01/2019 00:00:00
Remarks: